Sataa Sallami, Ramzi Mejri, Mohamed Chelif, Imed Ben Salah, Sami Ben Rhouma, Ghassen Hafsia, Yassine Nouira, Ali Horchani
Service d'Urologie, CHU La Rabra, Tunis, Tunisie.
Tunis Med. 2010 Apr;88(4):217-22.
Intrarectal lidocaine application and apical periprostatic nerve block are a safe technique that significantly reduces pain during transrectal prostate biopsy.
We compare prospectively the effectiveness of intrarectal lidocaine gel versus periprostatic lidocaine injection during transrectal ultrasound -guided prostate biopsy.
From June 2005 to February 2006, 100 consecutive patients underwent prostatic biopsies. Patients were randomized to receive 10 cc of 2% lidocaine gel in endorectally (Group I), 10 cc of 1% lidocaine solution injected into the prostate apex to induce bilateral periprostatic nerve block (Group II), or intrarectal 10 cc of ultrasound gel as placebo (Groupe III). Pain was evaluated by a 10-point linear visual analogue pain scale (VAS), and a 5-point digital visual scale (DVS). The side effects of the drugs and complications were also evaluated.
The three groups counted respectively: 33, 33 and 34 patients and were statically comparable as the age, prostate volume, PSA level and the number of biopsies. The mean pain score on the VAS was respectively 4,1;4,6 and 3,5 for the three groups. The DVS score was 2,5; 2,8 and 2,15 (p < 0.001). Pain scores were significantly lower in Group 3 and equivalent between Groups 1 and 2. There is no difference in complication rate between the three groups.
Compared to intrarectal lidocaine application, apical periprostatic nerve block is a safe technique that significantly reduces pain during transrectal prostate biopsy, with no increase in the complication rate.
直肠内应用利多卡因和前列腺尖周神经阻滞是一种安全的技术,可显著减轻经直肠前列腺活检时的疼痛。
我们前瞻性地比较经直肠超声引导下前列腺活检时直肠内利多卡因凝胶与前列腺周围注射利多卡因的有效性。
2005年6月至2006年2月,100例连续患者接受前列腺活检。患者被随机分为三组,分别为直肠内注入10毫升2%利多卡因凝胶(第一组)、向前列腺尖部注射10毫升1%利多卡因溶液以诱导双侧前列腺周围神经阻滞(第二组)或直肠内注入10毫升超声凝胶作为安慰剂(第三组)。通过10分线性视觉模拟疼痛量表(VAS)和5分数字视觉量表(DVS)评估疼痛。还评估了药物的副作用和并发症。
三组分别有33、33和34例患者,在年龄、前列腺体积、前列腺特异性抗原(PSA)水平和活检次数方面具有统计学可比性。三组的VAS平均疼痛评分分别为4.1、4.6和3.5。DVS评分分别为2.5、2.8和2.15(p<0.001)。第三组的疼痛评分显著较低,第一组和第二组相当。三组之间的并发症发生率无差异。
与直肠内应用利多卡因相比,前列腺尖周神经阻滞是一种安全的技术,可显著减轻经直肠前列腺活检时的疼痛,且不增加并发症发生率。